Altria’s Stock Has a Surprising 10-Year Return. Dividends Tell the Story

Altria spent a decade writing down bad bets, watching cigarette volumes shrink, and losing ground on smoke-free products. Yet investors who stuck around still came out ahead, and the reason has almost nothing to do with the stock price.

Published October 22, 2026, 8:45am ET · 2 min read

A close-up view of an open white and red cigarette carton. Inside, several brown-filtered cigarettes are interspersed with three rolled-up US dollar bills of different denominations, standing upright like cigarettes. The background is a plain light gray.
US dollar bills stand upright among cigarettes in a pack, symbolizing the financial aspects and investment returns within the tobacco industry, a key theme for companies like Altria. © IPGGutenbergUKLtd / iStock

A decade ago, Altria (NYSE:MO | MO Price Prediction) was a cigarette maker known for a big dividend. It still is. For anyone who held the stock over those 10 years, the dividend accounts for nearly all of the return.

A Decade Spent Trying to Replace the Cigarette

Altria spent heavily to move beyond smoking, and most of those deals went badly. Its JUUL stake was written down, and its heated tobacco partnership with Philip Morris International (NYSE:PM) was unwound. The NJOY e-vapor acquisition led to $2.2B in non-cash impairments in 2025, and NJOY ACE is not returning to market in 2026.

The core business kept shrinking. Domestic cigarette volumes fell 10.0% in 2025, and Marlboro’s retail share slipped to 39.5% in Q2 2026. Price increases still pushed adjusted EPS to $5.42 in 2025.

MO earnings explorer

The dividend grew the whole time. The quarterly payout rose from $0.61 in late 2016 to $1.11 in September 2026, with at least one increase each calendar year.

Your $1,000 Became $2,312, Mostly From Dividends.

Altria figures include reinvested dividends. S&P 500 figures track the price change of the SPDR S&P 500 ETF (NYSEARCA:SPY).

1-Year Return

  • Initial Investment: $1,000
  • Current Value: $1,237.80
  • Total Return: 23.78%
  • S&P 500 (same period): $1,151.50 (15.15%)

5-Year Return

  • Initial Investment: $1,000
  • Current Value: $2,255.70
  • Total Return: 125.57%
  • Annualized Return: 17.67%
  • S&P 500 (same period): $1,705.90 (70.59%)

10-Year Return

  • Initial Investment: $1,000
  • Current Value: $2,312.10
  • Total Return: 131.21%
  • Annualized Return: 8.74%
  • S&P 500 (same period): $3,612.50 (261.25%)

Look at the share price alone and the decade barely moved. The stock closed at $63.70 in October 2016, so without dividends, $1,000 would be worth only $1,159, a 15.9% gain. Reinvested dividends added $1,153, or roughly 88% of the total gain.

Staying in took patience. Counting dividends, shares fell 49% between June 2017 and March 2020. Your entry date mattered a lot. Investors who bought in 2021 more than doubled their money and beat the index, while 10-year holders fell well short of the S&P 500.

Why Altria Still Appeals to Income Investors

Altria fits investors who want a steadily growing income stream and can live with a shrinking core business. It fits less well for investors who need to keep up with the broader market. (Building a portfolio you can live off without ever selling a share is the whole premise of our free dividend ladder guide, here.)

The bull case: The forward dividend is $4.44 a year, 2026 adjusted EPS guidance is $5.61 to $5.72, on! PLUS is now in 120,000 stores, and nicotine pouches make up 59.9% of the oral tobacco category.

The bear case: After a 34.38% gain so far this year, the stock sits at $73.90. That is above the $70 average analyst target and close to the $75.85 52-week high. Illicit vapes and a weak record in smoke-free products are still real risks.

MO price target
MO analyst ratings

Altria’s case rests on income. Over the past decade, nearly all of Altria’s return came from its dividend checks, and only investors who reinvested them finished well ahead.

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →